Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism': author's response.
作者信息
Bitzer Johannes
机构信息
Chairman, Department of Obstetrics and Gyneecology, University Hospital Basel, Basel, Switzerland;
出版信息
J Fam Plann Reprod Health Care. 2013 Oct;39(4):304-5. doi: 10.1136/jfprhc-2013-100710.
PMID:24062506
Abstract
摘要
相似文献
1
Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism': author's response.
J Fam Plann Reprod Health Care. 2013 Oct;39(4):304-5. doi: 10.1136/jfprhc-2013-100710.
2
Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism'.
J Fam Plann Reprod Health Care. 2013 Oct;39(4):304. doi: 10.1136/jfprhc-2013-100693.
3
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
J Fam Plann Reprod Health Care. 2013 Jul;39(3):156-9. doi: 10.1136/jfprhc-2013-100624. Epub 2013 Apr 12.
4
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
Eur J Contracept Reprod Health Care. 2013 Jun;18(3):143-7. doi: 10.3109/13625187.2013.792637. Epub 2013 Apr 12.
5
Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.
Thromb Haemost. 2018 May;118(5):922-928. doi: 10.1055/s-0038-1641152. Epub 2018 Apr 3.
6
[Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
Gynecol Obstet Fertil Senol. 2018 Dec;46(12):823-833. doi: 10.1016/j.gofs.2018.10.007. Epub 2018 Oct 30.
7
Systemic hormonal contraception and risk of venous thromboembolism.
Acta Obstet Gynecol Scand. 2022 Aug;101(8):846-855. doi: 10.1111/aogs.14384. Epub 2022 May 27.
8
Epidemiology of hormonal contraceptives-related venous thromboembolism.
Eur J Endocrinol. 2014 Dec;171(6):R221-30. doi: 10.1530/EJE-14-0527. Epub 2014 Jul 10.
9
The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.
Am J Obstet Gynecol. 2011 Oct;205(4 Suppl):S9-13. doi: 10.1016/j.ajog.2011.06.057.
10
Specific oral contraceptive use and venous thromboembolism resulting in hospital admission.
N Z Med J. 2004 Nov 26;117(1206):U1176.
引用本文的文献
1
Assessing the Impact on Health of Pharmacovigilance Activities: Example of Four Safety Signals.
Drug Saf. 2021 May;44(5):589-600. doi: 10.1007/s40264-021-01047-1. Epub 2021 Feb 19.
Zotero 插件